Genomenon

Genomenon provides software, data, and services for genomic information analysis, structuring the biomedical literature into real-world evidence that precision medicine programs and clinical labs need for variant interpretation. The company's AI reads every word of millions of articles and data sources from the biomedical literature across 18,000 journals, 11.2 million full-text articles, and 3.7 million supplemental tables and datasets, then its scientists analyze, structure, and curate the data to deliver traceable, regulatory-grade evidence at scale. Genomenon's product portfolio includes Mastermind (providing access to article information on more than 26 million variants and curated germline variant content for clinical labs, enabling AI-powered literature search with expert-curated evidence at the variant level to reduce VUS rates and accelerate case sign-outs), the Cancer Knowledgebase (CKB, used to interpret cancer variants by connecting them to therapies and clinical trials for comprehensive and reliable genomic test interpretation), Real-World Evidence builds (custom evidence builds giving biopharma teams the variant, patient, and prevalence picture for broader labels, more eligible patients, and defensible regulatory filings), and Genetic Disease Sponsorship programs (providing clinicians and researchers open access to curated genetic evidence). The company's three-step process of identify, structure, and curate transforms hidden evidence into confident decisions for drug development teams (preventing genetic variants from being left out of labels and ensuring regulatory files are built on complete evidence) and clinical labs (preventing VUS misclassifications and accelerating diagnoses). Genomenon differentiates itself through its ability to read deeply into full-text articles and supplemental data that standard tools cannot access, its combination of AI-powered search with expert scientist curation, and its regulatory-grade evidence suitable for FDA/EMA submissions. Founded in 2014 and headquartered in Ann Arbor, United States, Genomenon has raised approximately $36.8 million in a Series B round backed by Beringea, Spring Mountain Capital, Broadoak Capital Partners, Green Park & Golf Ventures, University of Michigan-Ann Arbor, IrishAngels, Invest Detroit, Red Cedar, Michigan Rise, Atain Insurance Companies, Michigan Angel Fund, Riverine Ventures, Three Leaf Ventures, Invest Michigan, and others.

Data as a Service > Industries > Healthcare Data > Genome Data,

Life Sciences Tech > Research & Development > Drug Informatics > Scientific Literature > Online Search Portals > Health Databases,

Genomics > Genome Informatics > Sequence Analysis